NanOptima Limited

NanOptima Limited is a drug delivery company headquartered at Alderley Park, Cheshire, founded in 2016. It has developed the NAAmatrix™ platform, a bioresorbable natural amino acid matrix engineered for sustained ocular drug delivery. Lead application is wet AMD (age-related macular degeneration) treatment, reducing intravitreal injection frequency. Funded by Deepbridge Capital.